Medicare Enrolled
Dr. Alexander Perkelvald, MD
Endocrinology · Brooklyn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Perkelvald from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Perkelvald?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Perkelvald
Dr. Alexander Perkelvald is an endocrinology specialist in Brooklyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Perkelvald performed 2,275 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Perkelvald received a total of $299,571 from 59 pharmaceutical and/or device companies across 1005 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Perkelvald is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 25% volume in NY
$299,571 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,275
Medicare services
Top 25% in NY for endocrinology
Not available
Unique patients (not deduplicated)
$104
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,210 | $112 | $170 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
574 | $105 | $160 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
173 | $147 | $250 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
131 | $30 | $70 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
64 | $81 | $120 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
33 | $13 | $30 |
| Ultrasound-guided fine needle aspiration biopsy, each additional growth This procedure involves using ultrasound guidance to perform a fine needle aspiration biopsy on an additional growth during the same session. |
27 | $55 | $200 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
22 | $124 | $200 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
21 | $70 | $110 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
20 | $57 | $80 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$299,571
Total received (2018-2024)
Avg $42,796/year across 7 years
Top 3% in NY for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
1,005
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$25,355
2023
$31,226
2022
$64,137
2021
$55,828
2020
$40,449
2019
$39,173
2018
$43,402
Payments by company (2024)
Dexcom, Inc.
$8,845
Novo Nordisk Inc
$7,019
ABBVIE INC.
$4,080
Intra-Sana Laboratories
$3,362
Corcept Therapeutics
$711
Lilly USA, LLC
$211
Novartis Pharmaceuticals Corporation
$197
Amneal Pharmaceuticals LLC
$154
Boehringer Ingelheim Pharmaceuticals, Inc.
$150
IRONWOOD PHARMACEUTICALS, INC
$93
Kyowa Kirin, Inc.
$72
Insulet Corporation
$64
Xeris Pharmaceuticals, Inc.
$63
SANOFI-AVENTIS U.S. LLC
$50
AstraZeneca Pharmaceuticals LP
$47
Amgen Inc.
$41
CeQur Corporation
$40
Currax Pharmaceuticals LLC
$33
AIMMUNE THERAPEUTICS, INC.
$31
Chiesi USA, Inc.
$29
Ardelyx, Inc.
$28
TheracosBio, LLC
$24
Tandem Diabetes Care, Inc.
$15
Top 3 companies account for 78.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$156,223
Dexcom, Inc.
$48,709
AstraZeneca Pharmaceuticals LP
$35,981
Intuity Medical Inc
$10,753
AbbVie Inc.
$9,663
DEXCOM, INC.
$9,169
Kowa Pharmaceuticals America, Inc.
$6,420
ABBVIE INC.
$4,261
AbbVie, Inc.
$3,982
Intra-Sana Laboratories
$3,452
SANOFI-AVENTIS U.S. LLC
$1,301
Amgen Inc.
$917
Lilly USA, LLC
$784
Amneal Pharmaceuticals LLC
$782
Corcept Therapeutics
$711
Bayer HealthCare Pharmaceuticals Inc.
$699
Boehringer Ingelheim Pharmaceuticals, Inc.
$641
Novartis Pharmaceuticals Corporation
$605
Ironwood Pharmaceuticals, Inc
$336
Ipsen Biopharmaceuticals, Inc
$333
Xeris Pharmaceuticals, Inc.
$298
Insulet Corporation
$277
Amarin Pharma Inc.
$234
CeQur Corporation
$230
Horizon Therapeutics plc
$221
Shire North American Group Inc
$218
Allergan Inc.
$168
ARBOR PHARMACEUTICALS, INC.
$166
IRONWOOD PHARMACEUTICALS, INC
$163
Amryt Pharma Holdings Ltd
$160
Radius Health, Inc.
$159
Merck Sharp & Dohme Corporation
$131
Pharmacosmos Therapeutics Inc.
$125
Arbor Pharmaceuticals, Inc.
$124
Kyowa Kirin, Inc.
$118
Currax Pharmaceuticals LLC
$112
Regeneron Healthcare Solutions, Inc.
$93
NESTLE HEALTHCARE NUTRITION INC.
$91
Janssen Pharmaceuticals, Inc
$71
Abbott Laboratories
$69
Nestle HealthCare Nutrition Inc.
$61
VistaPharm, Inc.
$60
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$55
Zealand Pharma US, Inc.
$55
Tandem Diabetes Care, Inc.
$38
Gemini Laboratories, LLC
$38
Novo Nordisk AS
$31
AIMMUNE THERAPEUTICS, INC.
$31
Takeda Pharmaceuticals U.S.A., Inc.
$30
Chiesi USA, Inc.
$29
Ardelyx, Inc.
$28
TheracosBio, LLC
$24
VIVUS LLC
$22
Avanir Pharmaceuticals, Inc.
$22
Allergan, Inc.
$21
LifeScan, Inc.
$20
GlaxoSmithKline, LLC.
$20
Echosens North America, Inc.
$20
IBSA Pharma Inc.
$19
Top 3 companies account for 80.4% of all-time payments
Associated products mentioned in payments ›
ANORO · Aimovig · BAQSIMI · Brenzavvy · CONTRAVE · CREON · CYCLOSET · CeQur Simplicity · Creon · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · DIABETES - DISEASE · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FARXIGA · FIASP · FibroScan · FreeStyle Libre · GVOKE HYPOPEN · GVOKE PFS · IBSRELA · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LYUMJEV · Linzess · Livalo · MOUNJARO · MYCAPSSA · Monoferric · NATPARA · NUEDEXTA · ONZETRA XSAIL · Omnipod · OneTouch Verio Reflect · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pancreaze · Pogo Automatic Blood Glucose Monitoring System · Prolia · RECORLEV · RELTONE 200 MG · RELTONE 400 MG · RYBELSUS · Repatha · Rybelsus · SOLIQUA 100/33 · SOMATULINE DEPOT · SPIRIVA RESPIMAT · STEGLATRO · STEGLUJAN · SYNTHROID · Saxenda · Somatuline Depot · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULANCE · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · UBRELVY · UNITHROID · VIBERZI · Vascepa · Victoza · Wegovy · ZEGALOGUE · ZENPEP · ZEPBOUND · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
635
County median income
$78,548
Nearest hospital to ZIP centroid (approximate)
NEW YORK COMMUNITY HOSPITAL OF BROOKLYN, INC.
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Perkelvald is a clinical cardiology specialist, with above-average Medicare volume (top 25% in NY), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Perkelvald experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Perkelvald performed 1,210 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Perkelvald receive payments from pharmaceutical companies?
Yes. Dr. Perkelvald received a total of $299,571 from 59 companies across 1,005 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Perkelvald's costs compare to other endocrinologists in Brooklyn?
Dr. Perkelvald's average Medicare payment per service is $104. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Perkelvald) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Brooklyn
Browse endocrinologists in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in NY
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in NY
Which NY endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Dexcom, Inc. Payments to Doctors
See all physicians who received payments from Dexcom, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology